Outcomes of pregnancy in neuromyelitis optica patients: turkish multicenter study data

dc.contributor.authorAltintas, A.
dc.contributor.authorUygunoglu, U.
dc.contributor.authorTerzi, M.
dc.contributor.authorBoz, C.
dc.contributor.authorSaip, S.
dc.contributor.authorKoseoglu, M.
dc.contributor.authorSiva, A.
dc.date.accessioned2026-08-12T18:12:52Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -- SEP 14-17, 2016 -- London, ENGLAND
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipTeva; Merck Serono; Gen Ilac; Bayer Schering; Novartis; Sanofi Genzyme
dc.description.sponsorshipA. Altintas: She received honoraria, research and travel grants from Teva, Merck Serono, Gen Ilac, Bayer Schering, NovartisA. Siva: He received honoraria, research and travel grants from Teva, Merck Serono, Gen Ilac, Bayer Schering, Novartis, Sanofi Genzyme
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis
dc.identifier.endpage406
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.startpage405
dc.identifier.urihttps://hdl.handle.net/11508/64083
dc.identifier.volume22
dc.identifier.wosWOS:000383267202012
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherSage Publications Ltd
dc.relation.ispartofMultiple Sclerosis Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleOutcomes of pregnancy in neuromyelitis optica patients: turkish multicenter study data
dc.typeConference Object

Dosyalar